PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Kuehn, Thorsten
TI  - Sentinel Lymph Node Biopsy before or after Neoadjuvant Chemotherapy: Final Results from the SENTINA Trial
DP  - 2013 Mar 01
TA  - MD Conference Express
PG  - 14--14
VI  - 12
IP  - 20
4099  - http://mdc.sagepub.com/content/12/20/14.1.short
4100  - http://mdc.sagepub.com/content/12/20/14.1.full
AB  - For patients with breast cancer who undergo primary surgery, sentinel lymph node biopsy (SLNB) is the standard staging procedure to determine the axillary status when the patient is clinically node negative [D'Angelo-Donovan DD et al. Surg Oncol 2012]. However, for patients who undergo neoadjuvant chemotherapy, the optimal role and timing of SLNB is still unclear. This article presents final results from the prospective German, multi-institutional Sentinel Neoadjuvant [SENTINA] trial.